ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Neuropace Inc

Neuropace Inc (NPCE)

7.69
0.25
( 3.36% )
Updated: 15:55:31

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
7.69
Bid
7.67
Ask
7.72
Volume
69,615
7.30 Day's Range 8.0099
3.91 52 Week Range 18.15
Market Cap
Previous Close
7.44
Open
7.42
Last Trade
24
@
7.67
Last Trade Time
15:56:03
Financial Volume
$ 537,615
VWAP
7.7227
Average Volume (3m)
127,911
Shares Outstanding
28,768,128
Dividend Yield
-
PE Ratio
-6.76
Earnings Per Share (EPS)
-1.15
Revenue
65.42M
Net Profit
-32.96M

About Neuropace Inc

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically ... NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Neuropace Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NPCE. The last closing price for Neuropace was $7.44. Over the last year, Neuropace shares have traded in a share price range of $ 3.91 to $ 18.15.

Neuropace currently has 28,768,128 shares outstanding. The market capitalization of Neuropace is $214.03 million. Neuropace has a price to earnings ratio (PE ratio) of -6.76.

NPCE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.375.054644808747.328.00996.6505787.03391061CS
41.2719.78193146426.428.00996.211814707.27006426CS
12-6.21-44.676258992813.914.5056.151279118.35067129CS
26-3.56-31.644444444411.2518.156.1511633211.28912561CS
523.4681.79669030734.2318.153.91958679.88306317CS
156-16.52-68.236266005824.2124.971.22671078.7001941CS
260-15.56-66.924731182823.2527.381.227677511.54117136CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

Your Recent History

Delayed Upgrade Clock